Clinical Trial Update: Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy [EARLY_Phase 1]

View source ↗

Summary

This report summarizes results from a Phase 1 trial of rituximab given as neoadjuvant therapy before radical prostatectomy in men with prostate cancer. Results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Christopher Kane | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2026-03-12